CS logo
small CS logo
National Hospital Organization Hokkaido Medical Center

Sapporo, Hokkaido, Japan
こくりつびょういんきこうほっかいどういりょうセンター

About National Hospital Organization Hokkaido Medical Center


国立病院機構北海道医療センターは、札幌市西区山の手にある病院。2010年に国立病院機構西札幌病院と国立病院機構札幌南病院が統合して開院した。札幌市立山の手養護学校と渡り廊下で接続しており、通院・入院している児童に対応している。国立病院機構八雲病院の機能移転に伴い、新病棟を建設する予定である。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at National Hospital Organization Hokkaido Medical Center


During the past decade, National Hospital Organization Hokkaido Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Hokkaido Medical Center" #1 sponsor was "Mitsubishi Tanabe Pharma America Inc." with 3 trials, followed by "Japan Multinational Trial Organization" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Shire" with 2 trials sponsored and "AstraZeneca" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Hokkaido Medical Center" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

Clinical Trials Conditions at National Hospital Organization Hokkaido Medical Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Hokkaido Medical Center" are "Lung Cancer" (3 trials), "ALS" (2 trials), "Nervous System Diseases" (2 trials), "Alzheimer's Disease" (1 trials) and "Amyotrophic Lateral Sclerosis (ALS)" (1 trials). Many other conditions were trialed in "National Hospital Organization Hokkaido Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Hokkaido Medical Center


Most popular intervention types in "National Hospital Organization Hokkaido Medical Center" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "MT-1186" (3 trials), "SHP615" (2 trials), "Eplerenone" (1 trials) and "Lanabecestat" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Hokkaido Medical Center


The vast majority of trials in "National Hospital Organization Hokkaido Medical Center" are 14 trials for "All" genders.

Clinical Trials Status at National Hospital Organization Hokkaido Medical Center


Currently, there are NaN active trials in "National Hospital Organization Hokkaido Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in National Hospital Organization Hokkaido Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Hokkaido Medical Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".